Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Retinol saturase coordinates liver metabolism by regulating ChREBP activity

[thumbnail of Article]
Preview
PDF (Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB
[thumbnail of Supplementary Files]
Preview
PDF (Supplementary Files) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
810kB

Item Type:Article
Title:Retinol saturase coordinates liver metabolism by regulating ChREBP activity
Creators Name:Heidenreich, S., Witte, N., Weber, P., Goehring, I., Tolkachov, A., von Loeffelholz, C., Döcke, S., Bauer, M., Stockmann, M., Pfeiffer, A.F.H., Birkenfeld, A.L., Pietzke, M., Kempa, S., Muenzner, M. and Schupp, M.
Abstract:The liver integrates multiple metabolic pathways to warrant systemic energy homeostasis. An excessive lipogenic flux due to chronic dietary stimulation contributes to the development of hepatic steatosis, dyslipidemia and hyperglycemia. Here we show that the oxidoreductase retinol saturase (RetSat) is involved in the development of fatty liver. Hepatic RetSat expression correlates with steatosis and serum triglycerides (TGs) in humans. Liver-specific depletion of RetSat in dietary obese mice lowers hepatic and circulating TGs and normalizes hyperglycemia. Mechanistically, RetSat depletion reduces the activity of carbohydrate response element binding protein (ChREBP), a cellular hexose-phosphate sensor and inducer of lipogenesis. Defects upon RetSat depletion are rescued by ectopic expression of ChREBP but not by its putative enzymatic product 13,14-dihydroretinol, suggesting that RetSat affects hepatic glucose sensing independent of retinol conversion. Thus, RetSat is a critical regulator of liver metabolism functioning upstream of ChREBP. Pharmacological inhibition of liver RetSat may represent a therapeutic approach for steatosis.
Keywords:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Fatty Liver, Glucose, Hepatocytes, Inbred C57BL Mice, Lipid Metabolism, Liver, Oxidoreductases Acting On CH-CH Group Donors, Triglycerides, Animals, Mice
Source:Nature Communications
ISSN:2041-1723
Publisher:Nature Publishing Group
Volume:8
Number:1
Page Range:384
Date:30 August 2017
Official Publication:https://doi.org/10.1038/s41467-017-00430-w
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library